Psychiatr. praxi. 2012;13(2):50-53

Circadian rhythms and depression

MUDr.Michal Marąálek, CSc.
Psychiatrická léčebna Bohnice, Praha

There is an evidence for the link betweeen circadian rhythms dysfunction and pathophysiology of depression. Manipulation of the

circadian timing system via sleep deprivation, light therapy, or antidepressant agomelatine with new mode of action may represent

inovative style of treatment in major depression.

Keywords: circadian rhythms, major depression, phototherapie, sleep deprivation, lithium, fluoxetine, agomelatine

Published: April 23, 2012  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Marąálek M. Circadian rhythms and depression. Psychiatr. praxi. 2012;13(2):50-53.
Share...
Download citation
  • BibTeX (.bib)
  • Bookends (.ris)
  • EasyBib (.ris)
  • EndNote (.enw)
  • EndNote 8 (.xml)
  • ISI WoS (.isi)
  • Medlars (.medlars)
  • Mendeley (.ris)
  • MODS (.xml)
  • Papers (.ris)
  • RefWorks (.txt)
  • RefManager (.ris)
  • RIS (.ris)
  • MS Word (.xml)
  • Zotero (.ris)
    • Open full article

    References

    1. Wirz-Justice A. Biological rhythm disturbances in mood disorders. Int Clin Psychopharmacol 2006; (Suppl 1): 511-515. Go to original source... Go to PubMed...
    2. Moore RY, Speh P. Serotonin innervation of the primate suprachiasmatic nucleus. Brain Res 2004; 1010: 169-173. Go to original source... Go to PubMed...
    3. Mendlewicz J. Disruption of the circadian timing systems. Molecular mechanism in mood disorders. CNS Drugs 2009; 23(Suppl 2): 15-26. Go to original source... Go to PubMed...
    4. Van Culter E, Leprouolt R, Kupfer DJ. Effects of gender and age on the levels and circadian rhythmicity of plasma cortisol. J Clin Endocrinol Metab 1996; 81: 2468-2473. Go to original source...
    5. Duncan WC Jr. Circadian rhythms and the pharmacology of affective illness. Pharmacol Ther 1996; 71: 253-312. Go to original source... Go to PubMed...
    6. Thase ME, Carpenter L, Kupfer DJ, Frank E. Clinical significance of reversed vegetative subtypes of major depression. Psychopharmacol Bull 1991; 27: 17-22. Go to PubMed...
    7. Borbély AA, Wirz-Justice A. Sleep, sleep deprivation and depression. Hum Neurobiol 1982; 1: 205-210. Go to original source... Go to PubMed...
    8. Buysse DJ, Frank E, Lowe KK, et al. Electroencephalographic sleep correlates of episode and vulnerability of recurrence in depression. Biol Psychiatry 1997; 41: 406-418. Go to original source... Go to PubMed...
    9. Thase ME, Franciczka AL, Berman SR, et al. Electroencephalographic sleep profiles before and after cognitive behavior therapy of depression. Arch Gen Psychiatry 1998; 55: 138-144. Go to original source... Go to PubMed...
    10. Avery D, Wildschiodtz G, Rafaelsen O. REM latency and temperature in affective disorders before and after treatment. Biol Psychiatry 1982; 17: 463-470.
    11. Parry BL, Mendelson WB, Duncan WC, et al. Longitudinal sleep EEG, temperature, and aktivity measurements Gross the menstrual cycle in patiens with premenstrual depression and in age-matched controls. Psychiatry Res 1989; 30: 285-303. Go to original source... Go to PubMed...
    12. Linkowski C, Mendlewicz J, Leclercq R, Van Cauter E. The 24 hour profile of adrenocorticotropin and cortisol in major depressive illness. J Clin Endocinol Metab 1985, 61: 429-438. Go to original source... Go to PubMed...
    13. Parry BL, Newton RP. Chronobiological basis of fiale - specific mood disorders. Neuropsychopharmacology 2007; 25(Suppl 5): 5102-5108. Go to original source... Go to PubMed...
    14. Carvalho LA, Gorenstein C, Moreno RA, et al. Melatonin levels in drug-free patiens with major depression from the southern hemisphere. Psychoneuroendocrinology 2006; 31: 761-768. Go to original source... Go to PubMed...
    15. Giedke H, Schwarzler F. Therapeutic use of sleep deprivation in depression. Sleep Med Rev 2002; 6: 361-377. Go to original source...
    16. Gükman G, Byrne B, Pineda C, et al. Light therapy for seassonal affective disorder with blue narrow-band light-emitting diodes (LEDs). Biol Psychiatry 2006; 59: 502-507. Go to original source... Go to PubMed...
    17. Quiroz JA, Gould TD, Manji HK. Molecular effects of lithium. Mol Interv 2004; 4: 259-272. Go to original source... Go to PubMed...
    18. LeSauter J, Silver R. Lithium lenghtens the period of circadian rhythms in kesioned hamsters bearing SCN grafts. Biol Psychiatry 1993, 34: 75-83. Go to original source... Go to PubMed...
    19. Ogden CA, Rich ME, Schork NJ, et al. Candidate genes, pathways and mechanisms for bipolar (manic-depressive) and related disorders. An expanded convergent functional genomics approach. Mol Psychiatry 2004; 9: 1007-1029. Go to original source... Go to PubMed...
    20. Pickard GE, Rea MA. Serotonergic innervation of the hypothalamic suprachiasmatic nucleus and photic regulation of circadian rhythms. Biol Cell 1998; 89: 513-523. Go to original source... Go to PubMed...
    21. Uz T, Ahmed R, Akhisaroglu M, Kurtuncu M, et al. Effect of fluoxetine and cocaine on the expression of clock genes in the hippocampus and striatum. Neuroscience 2005; 134: 1309-1316. Go to original source... Go to PubMed...
    22. Sprouse J, Braseton J, Reynolds L. Fluoxetine modulates the circadian biological clock via phase advances of suprachiasmatic nucleus neuronal firing. Biol Psychiatry 2006; 60: 896-899. Go to original source... Go to PubMed...
    23. Dolberg OT, Hirschmann S, Grunhaus L. Melatonin for the treatment of sleep disturbances in major depressive disorder. Am J Psychiatry 1998; 155: 1119-1121. Go to original source... Go to PubMed...
    24. Millan MJ, Gobert A, Lejeune F, et al. The novel melatonin agonist agomelatine (5200 98) in an antagonist at 5-hydroxytryptamine 2C receptors, blokade of which enhances the aktivity of frontocortical dopaminergic and adrenergic pathways. J Pharmacol Exp Ther 2003, 306: 954-964. Go to original source... Go to PubMed...
    25. Quera SalvaMA, Vanier B, Loredo J, et al. Major depressive disorder, sleep EEG and agomelatine: an open - label study. Int J Neuropsychopharmacol 2007; 10: 691-696. Go to original source...
    26. Lemoine P, Guilleminault C, Alvarez E. Improvement in subjective sleepin major depressive disorder with a novel antidepressant agomelatine: randomized, double-blind comparison with venlafaxine. J. Clin Psychiatry 2007; 68: 1723-1732. Go to original source... Go to PubMed...
    27. ©vestka J, Mohr P. Agomelain - antidepresivum s novým mechanismem působení. Psychiatrie 2010; 14: 98-108.
    28. Stahl SM. Novel mechanism of antidepressant action: norepinephrine and dopamine disinhibition (NDDI) plus melatonergic agonism. Int J Neuropsychopharmacol 2007; 10: 575-578. Go to original source... Go to PubMed...

    Return to the content


    Psychiatry for Practice

    Madam, Sir,
    please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
    Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

    I declare:

    1. that I have met the above instruction
    2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited

    No
    Yes

    If your statement is not true, please be aware
    that brings the risk of danger to their health or the health of others.